Loading...
10 Australia Diabetes Care Drugs Reports
Country Covered: Australia
Study Period: 2019 - 2030
Major Players: Novo Nordisk, Sanofi, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company
Country Covered: Australia
Study Period: 2019 - 2030
Major Players: Eli Lilly and Company, Boehringer Ingelheim, AstraZeneca, Sanofi, Novo Nordisk
Country Covered: Australia
Study Period: 2019 - 2030
Major Players: AstraZeneca, Boehringer Ingelheim, Novo Nordisk, Eli Lilly and Company, Sanofi
Country Covered: Australia
Study Period: 2019 - 2030
Major Players: Sanofi, Novo Nordisk, Takeda Pharmaceuticals, Astellas Pharma, AstraZeneca
Country Covered: Australia
Study Period: 2019 - 2030
Major Players: Vivus, Roche, GlaxoSmithKline, Novo Nordisk, Currax Pharmaceuticals
Country Covered: Australia
Study Period: 2019 - 2030
Major Players: Convatec, 3M, Integra LifeSciences, Coloplast, Cardinal Health
Country Covered: Australia
Study Period: 2019 - 2030
Major Players: Novartis, Regeneron Pharmaceuticals, Abbvie, Roche, Oxurion
Country Covered: Australia
Study Period: 2019 - 2030
Major Players: Boehringer Ingelheim, Sanofi, Merck, Eli Lilly and Company, Novo Nordisk
Country Covered: Australia
Study Period: 2019 - 2030
Major Players: Eli Lilly and Company, Astellas Pharma, Sanofi, Janssen, AstraZeneca
Country Covered: Australia
Study Period: 2019 - 2030
Major Players: Merck, Sanofi, Amgen, AstraZeneca, Viatris
